IncFact
Company Profiles: Revenue, Growth, Competition

Principia Biopharma Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Principia Biopharma

Access the complete profile.

Principia Biopharma Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry4242 Drugs & Druggists' Sundries Merchant Wholesalers
Address220 East Grand Ave
South San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Principia Biopharma's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Principia Biopharma is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Principia Biopharma Annual Revenue and Growth Rate

Principia Biopharma Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Principia Biopharma's revenues are gauged from an analysis of company filings.



Principia Biopharma's Income Statement (based on Industry Averages)

Principia Biopharma P&L$ Millions
Revenue (Sales) Principia Biopharma Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

Principia Biopharma has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
September 5, 2018 24 100%$50 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Principia Biopharma is developing and marketing. Principia Biopharma doesn't have any recent trademark applications, indicating Principia Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
CLEEZISE
Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
08/24/2021
MIRGLEAU
Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
08/24/2021
RAPZULIT
Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
06/21/2021

See all trademarks and details in the Full Report.


Market Share of Principia Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Principia Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
AMERISOURCEBERGENConshohocken, PA100 
MCKESSONIrving, TX58 
CARDINAL HEALTH 119Dublin, OH42 
TAKEDA PHARMACEUTICALS AMERICALexington, MA31 
CATALENT PHARMA SOLUTIONSSomerset, NJ13 
OWENS & MINOR DISTRIBUTIONMechanicsville, VA11 
J M SMITHSpartanburg, SC3 
DAIICHI SANKYOBasking Ridge, NJ3 
HIKMA PHARMACEUTICALS USABerkeley Heights, NJ2 




Nearby Competitors

These companies are similar in business line and location to Principia Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
PACK4UMountain View, CA100 
PRINCIPIA BIOPHARMASouth San Francisco, CA83 
CROSSHAIR THERAPEUTICSSunnyvale, CA13 
BOOST BIOMESBrisbane, CA10 
APEXIMMUNE THERAPEUTICSSouth San Francisco, CA9 
INTACT THERAPEUTICSBelmont, CA5 




Future Competition: Principia Biopharma's Fastest Growing Competitors

These companies are in the same general field as Principia Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Principia Biopharma Competitors